Back to Search
Start Over
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.
- Source :
-
JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2014 Nov; Vol. 7 (11), pp. 1287-93. Date of Electronic Publication: 2014 Oct 15. - Publication Year :
- 2014
-
Abstract
- Objectives: The aim of this study was to evaluate the impact of intravascular ultrasound (IVUS) guidance on the final volume of contrast agent used in patients undergoing percutaneous coronary intervention (PCI).<br />Background: To date, few approaches have been described to reduce the final dose of contrast agent in PCIs. We hypothesized that IVUS might serve as an alternative imaging tool to angiography in many steps during PCI, thereby reducing the use of iodine contrast.<br />Methods: A total of 83 patients were randomized to angiography-guided PCI or IVUS-guided PCI; both groups were treated according to a pre-defined meticulous procedural strategy. The primary endpoint was the total volume contrast agent used during PCI. Patients were followed clinically for an average of 4 months.<br />Results: The median total volume of contrast was 64.5 ml (interquartile range [IQR]: 42.8 to 97.0 ml; minimum, 19 ml; maximum, 170 ml) in the angiography-guided group versus 20.0 ml (IQR: 12.5 to 30.0 ml; minimum, 3 ml; maximum, 54 ml) in the IVUS-guided group (p < 0.001). Similarly, the median volume of contrast/creatinine clearance ratio was significantly lower among patients treated with IVUS-guided PCI (1.0 [IQR: 0.6 to 1.9] vs. 0.4 [IQR: 0.2 to 0.6, respectively; p < 0.001). In-hospital and 4-month outcomes were not different between patients randomized to angiography-guided and IVUS-guided PCI.<br />Conclusions: Thoughtful and extensive use of IVUS as the primary imaging tool to guide PCI is safe and markedly reduces the volume of iodine contrast compared with angiography-alone guidance. The use of IVUS should be considered for patients at high risk of contrast-induced acute kidney injury or volume overload undergoing coronary angioplasty. (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy [MOZART]; NCT01947335).<br /> (Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Acute Kidney Injury blood
Acute Kidney Injury chemically induced
Acute Kidney Injury diagnosis
Acute Kidney Injury prevention & control
Aged
Biomarkers blood
Coronary Artery Disease diagnostic imaging
Creatinine blood
Female
Humans
Iohexol adverse effects
Male
Middle Aged
Percutaneous Coronary Intervention adverse effects
Risk Factors
Time Factors
Treatment Outcome
Contrast Media adverse effects
Coronary Angiography adverse effects
Coronary Artery Disease therapy
Iohexol analogs & derivatives
Percutaneous Coronary Intervention methods
Triiodobenzoic Acids adverse effects
Ultrasonography, Interventional
Subjects
Details
- Language :
- English
- ISSN :
- 1876-7605
- Volume :
- 7
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- JACC. Cardiovascular interventions
- Publication Type :
- Academic Journal
- Accession number :
- 25326742
- Full Text :
- https://doi.org/10.1016/j.jcin.2014.05.024